Active Biotech (Sweden) Price on December 3, 2024
ACTI Stock | SEK 0.11 0.02 15.38% |
If you're considering investing in Active Stock, it is important to understand the factors that can impact its price. As of today, the current price of Active Biotech stands at 0.11, as last reported on the 11th of December 2024, with the highest price reaching 0.12 and the lowest price hitting 0.11 during the day. Active Biotech appears to be out of control, given 3 months investment horizon. Active Biotech AB secures Sharpe Ratio (or Efficiency) of 0.014, which signifies that the company had a 0.014% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Active Biotech AB, which you can use to evaluate the volatility of the firm. Please makes use of Active Biotech's Risk Adjusted Performance of 0.0163, mean deviation of 11.1, and Downside Deviation of 15.71 to double-check if our risk estimates are consistent with your expectations.
Active Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Active |
Sharpe Ratio = 0.014
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ACTI | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
27.26 actual daily | 96 96% of assets are less volatile |
Expected Return
0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
0.01 actual daily | 1 99% of assets perform better |
Based on monthly moving average Active Biotech is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Active Biotech by adding it to a well-diversified portfolio.
Active Biotech Valuation on December 3, 2024
It is possible to determine the worth of Active Biotech on a given historical date. On December 3, 2024 Active was worth 0.16 at the beginning of the trading date compared to the closed value of 0.14. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Active Biotech stock. Still, in general, we apply an absolute valuation method to find Active Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Active Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Active Biotech's related companies.
Open | High | Low | Close | Volume | |
0.27 | 0.27 | 0.14 | 0.15 | 34,429,358 | |
12/03/2024 | 0.16 | 0.22 | 0.14 | 0.14 | 93,605,748 |
0.14 | 0.17 | 0.12 | 0.13 | 58,772,802 |
Backtest Active Biotech | | | Active Biotech History | | | Active Biotech Valuation | Previous | Next |
Active Biotech Trading Date Momentum on December 3, 2024
On December 04 2024 Active Biotech AB was traded for 0.13 at the closing time. The highest price during the trading period was 0.17 and the lowest recorded bid was listed for 0.12 . The volume for the day was 58.8 M. This history from December 4, 2024 contributed to the next trading day price decline. The overall trading delta to the next closing price was 7.14% . The overall trading delta to the current price is 14.29% . |
Active Biotech AB Fundamentals Correlations and Trends
By evaluating Active Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Active Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Active financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Active Biotech Stock history
Active Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Active is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Active Biotech AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Active Biotech stock prices may prove useful in developing a viable investing in Active Biotech
Active Biotech AB , a biotechnology company, develops drugs for the treatment of neurodegenerative diseases, autoimmunityinflammatory, and cancer. Active Biotech AB was incorporated in 1982 and is based in Lund, Sweden. Active Biotech operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 12 people.
Active Biotech Stock Technical Analysis
Active Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Active Biotech Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Active Biotech AB cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Active Biotech December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Active Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Active Biotech shares will generate the highest return on investment. By undertsting and applying Active Biotech stock market strength indicators, traders can identify Active Biotech AB entry and exit signals to maximize returns
Active Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Active Biotech's price direction in advance. Along with the technical and fundamental analysis of Active Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Active to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0163 | |||
Jensen Alpha | 0.3826 | |||
Total Risk Alpha | (4.06) | |||
Sortino Ratio | 0.0076 | |||
Treynor Ratio | (0.18) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Active Stock Analysis
When running Active Biotech's price analysis, check to measure Active Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Active Biotech is operating at the current time. Most of Active Biotech's value examination focuses on studying past and present price action to predict the probability of Active Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Active Biotech's price. Additionally, you may evaluate how the addition of Active Biotech to your portfolios can decrease your overall portfolio volatility.